Centre for Commercialization of Regenerative Medicine:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centre for Commercialization of Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9418
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre for Commercialization of Regenerative Medicine (CCRM) is a healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, biomaterials and devices manufacturing, and protocol development services. The center harnesses the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs. It provides business, scientific and technical services for its partners in regenerative medicine field. CCRM offers novel solutions in cell and vector process development and optimization, media formulation and development, genome editing, pluripotent stem cells and cell-based immunotherapies, among others. The center supports its partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. CCRM is headquartered in Toronto, Ontario, Canada.

Centre for Commercialization of Regenerative Medicine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Centre for Commercialization of Regenerative Medicine and Affigen Enter into Partnership 10
Hemostemix Enters into Co-Development Agreement with Commercialization of Regenerative Medicine 11
EMD Millipore Enters Into Co-Development Agreement With Centre for Commercialization of Regenerative Medicine 12
Centre for Commercialization of Regenerative Medicine – Key Competitors 13
Centre for Commercialization of Regenerative Medicine – Key Employees 14
Centre for Commercialization of Regenerative Medicine – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Commercialization of Regenerative Medicine, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centre for Commercialization of Regenerative Medicine and Affigen Enter into Partnership 10
Hemostemix Enters into Co-Development Agreement with Commercialization of Regenerative Medicine 11
EMD Millipore Enters Into Co-Development Agreement With Centre for Commercialization of Regenerative Medicine 12
Centre for Commercialization of Regenerative Medicine, Key Competitors 13
Centre for Commercialization of Regenerative Medicine, Key Employees 14

List of Figures
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Centre for Commercialization of Regenerative Medicine:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kaneka Corp (4118):企業の財務・戦略的SWOT分析
    Kaneka Corp (4118) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Legal & General Group Plc:企業の戦略・SWOT・財務情報
    Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report Summary Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Forty Seven Inc (FTSV):製薬・医療:M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • Bristow Group Inc:企業の戦略・SWOT・財務情報
    Bristow Group Inc - Strategy, SWOT and Corporate Finance Report Summary Bristow Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • InVivoScribe Technologies Inc:企業の製品パイプライン分析
    Summary InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company offer full range of hematology-oncology testing products and services. It’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent de …
  • Thales Deutschland GmbH:企業の戦略・SWOT・財務情報
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Beactica AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Beactica AB (Beactica) is a drug discovery company develops a pipeline of novel and mechanistically defined small molecule therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate ana …
  • PT XL Axiata Tbk (EXCL):企業の財務・戦略的SWOT分析
    PT XL Axiata Tbk (EXCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • AFT Pharmaceuticals Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary AFT Pharmaceuticals Pty Ltd (AFT Pharmaceuticals) is a manufacturer and distributor medical products. The company provides prescription and non-prescription products. Its products include moisturizers, calcium supplements, scalp ointments, eye drops, cracked heel creams, iron and folic acid …
  • Blue Coat Systems, Inc.:企業のM&A・事業提携・投資動向
    Blue Coat Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Blue Coat Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mudman Public Company Limited (MM):企業の財務・戦略的SWOT分析
    Mudman Public Company Limited (MM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Petrochemical Industries Co:企業の戦略的SWOT分析
    Petrochemical Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Pinnacle Entertainment Inc:戦略・SWOT・企業財務分析
    Pinnacle Entertainment Inc - Strategy, SWOT and Corporate Finance Report Summary Pinnacle Entertainment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Fraser & Neave Holdings Bhd:戦略・SWOT・企業財務分析
    Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Emirates Telecommunications Group Company PJSC:企業のM&A・事業提携・投資動向
    Emirates Telecommunications Group Company PJSC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Emirates Telecommunications Group Company PJSC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descriptio …
  • Apache Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Apache Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Apache Corp (Apache) is an independent upstream energy company, which carries out exploration, development and production of natural gas, crude oil and natural gas liquids (NGLs). It has onshore and offs …
  • Ominto Inc (OMNT):企業の戦略的SWOT分析
    Ominto Inc (OMNT) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Kuros Biosciences Ltd (KURN)-製薬・医療分野:企業M&A・提携分析
    Summary Kuros Biosciences Ltd (Kuros Biosciences) is a biotechnology company that develops products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specificall …
  • PT. Millennium Pharmacon International TBK (SDPC):企業の財務・戦略的SWOT分析
    PT. Millennium Pharmacon International TBK (SDPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆